| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $59,171,925 ) (Continued on the next page) |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R03HD104879 | Intercellular dynamics of cyclic nucleotides in ovarian follicles | 000 | 2 | NIH | 4/18/2022 | $82,000 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R21AG071047 | Fracture Repair in Aging: Identifying networks by miRNA and mRNA co-sequencing | 000 | 2 | NIH | 5/18/2022 | $205,000 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01AI150919 | The essential role of cyclin-dependent kinase CRK9 in trypanosome pre-mRNA processing | 000 | 2 | NIH | 2/11/2022 | $410,000 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01HL153835 | Perinuclear Signaling and Cardiac Hypertrophy | 000 | 2 | NIH | 3/17/2022 | $501,512 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01HL153835 | Perinuclear Signaling and Cardiac Hypertrophy | 001 | 2 | NIH | 5/31/2022 | $55,726 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01DA051671 | Enhancing Substance Use Treatment Services to Decrease Dropout and Improve Outpatient Treatment Utilization in Emerging Adults | 001 | 2 | NIH | 3/18/2022 | $69,195 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01DA051671 | Enhancing Substance Use Treatment Services to Decrease Dropout and Improve Outpatient Treatment Utilization in Emerging Adults | 000 | 2 | NIH | 2/3/2022 | $622,713 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R21CA258188 | (PQ1) Mechanisms for Early Onset Colorectal Cancer | 000 | 2 | NIH | 8/9/2022 | $186,468 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | T32AR079114 | Regenerative Engineering of Musculoskeletal Tissues- a Convergence Doctoral Training Program | 001 | 2 | NIH | 8/2/2022 | $161,406 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | T32AR079114 | Regenerative Engineering of Musculoskeletal Tissues- a Convergence Doctoral Training Program | 000 | 2 | NIH | 6/29/2022 | $191,669 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | F31NS124264 | Studying the Molecular Mechanism of Foxp1/2 Function Controlling the Cerebellar Development | 000 | 2 | NIH | 8/4/2022 | $42,544 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01DE030716 | Rspondin-Lgr Axis in Bone Regeneration | 000 | 3 | NIH | 7/20/2022 | $379,432 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R21DK122312 | The Monthly Cycling of Food Insecurity and Diabetes Risk | 000 | 3 | NIH | 7/12/2022 | $192,337 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 farmington ave, asb #3 | farmington | CT | 06032-1956 | HARTFORD | USA | 90DDUC0071 | University of Connecticut A.J. Pappanikou Center for Excellence in Developmental Disabilities Education, Research, and Service | 00 | 5 | ACL | 6/27/2022 | $577,735 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | U01HL156349 | Human cardiac microtissues with innate immune sensing to study adverse consequences of genome editing | 000 | 4 | NIH | 7/22/2022 | $737,026 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R03DE030526 | Cellular Senescence in mediating age related TMJ Degeneration | 000 | 2 | NIH | 7/25/2022 | $164,000 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01CA252045 | Microbiota, Metabolites, and Colon Neoplasia | 000 | 2 | NIH | 5/2/2022 | $649,547 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R35GM140631 | The Biology of Motile Cilia | 000 | 2 | NIH | 5/2/2022 | $749,898 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01AR078149 | Mechanisms and Treatment of Hajdu Cheney Syndrome | 000 | 2 | NIH | 6/29/2022 | $357,192 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01GM135592 | Substrate targeting mechanism of a DesCEND pathway | 000 | 3 | NIH | 5/18/2022 | $432,410 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01AR077534 | Studies of Osteoclast Lineage in Health and Diseases | 001 | 2 | NIH | 5/4/2022 | $38,946 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01AR077534 | Studies of Osteoclast Lineage in Health and Diseases | 000 | 2 | NIH | 12/3/2021 | $389,460 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R21EY031113 | Defining Corneal Schwann cells in Injury | 001 | 2 | NIH | 1/27/2022 | $17,220 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R21EY031113 | Defining Corneal Schwann cells in Injury | 000 | 2 | NIH | 12/20/2021 | $221,400 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01AG068860 | Reciprocal Modulation of the Microbiome and Cellular Senescence in Metabolic Dysfunction | 000 | 3 | NIH | 7/7/2022 | $535,801 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01DK125747 | Estrogen Receptor Signaling in Hematopoietic Stem Cell Proliferation and Mobilization | 000 | 3 | NIH | 6/15/2022 | $360,800 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01EY031593 | The Oxygen Sensing Mechanism in Retinal Endothelial Cells as a Novel Target to Suppress Ischemic Neovascularization | 000 | 3 | NIH | 6/24/2022 | $588,535 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01AI021747 | Genetics of HSV DNA Replication | 000 | 36 | NIH | 12/8/2021 | $791,737 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01DE013986 | Oral Epithelial Cells, Candida and PMN Activation | 000 | 18 | NIH | 7/18/2022 | $564,656 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R00ES029116 | Impacts of modifiable factors on personal exposures and acute health | 000 | 3 | NIH | 8/10/2022 | $249,000 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R00MH117271 | Prefontal Microcircuits Underlying Cognitive Flexibility | 000 | 3 | NIH | 4/30/2022 | $248,998 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01HL165220 | Establishing and reversing the functional consequences of Titin truncation mutations | 000 | 1 | NIH | 6/7/2022 | $566,102 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R56NS122753 | Engineered Matrices with Electrical and Chemical Stimulation for Peripheral Nerve Repair | 000 | 1 | NIH | 4/22/2022 | $410,100 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | F30NS129238 | The role of microglia as antigen presenting cells in Globoid Cell Leukodystrophy | 000 | 1 | NIH | 6/20/2022 | $42,274 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | F30NS129238 | The role of microglia as antigen presenting cells in Globoid Cell Leukodystrophy | 001 | 1 | NIH | 6/20/2022 | $0 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01AG076642 | Targeting p21-Highly Expressing Cells to Increase Lifespan and Healthspan in Old Age | 000 | 1 | NIH | 5/25/2022 | $497,766 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | H79SM085080 | Center for the Treatment of Developmental Trauma Disorders | 000 | 1 | SAMHSA | 6/30/2022 | $600,000 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R35GM146883 | Regulatory roles of the epitranscriptome and RNA structurome during vertebrate development | 000 | 1 | NIH | 7/21/2022 | $411,563 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01NS125405 | Therapeutic implications of purinergic receptor P2X4 in ischemic stroke | 001 | 1 | NIH | 6/9/2022 | $7,500 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01NS125405 | Therapeutic implications of purinergic receptor P2X4 in ischemic stroke | 000 | 1 | NIH | 6/3/2022 | $402,500 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01NS125405 | Therapeutic implications of purinergic receptor P2X4 in ischemic stroke | 002 | 1 | NIH | 6/28/2022 | $1,146 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01AR080131 | The role of Dot1L activity in chondrogenic differentiation | 000 | 1 | NIH | 7/21/2022 | $464,842 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01AR081659 | Extracellular regulation of bone mass by transforming growth factor-?-related ligands and their binding proteins | 000 | 1 | NIH | 7/21/2022 | $638,893 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01GM144483 | Protein Phosphatase 1 Holoenzyme Formation | 000 | 1 | NIH | 7/26/2022 | $400,301 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R21AA029734 | Implementing Mobile Technology for Unhealthy Alcohol Use in Emergency Departments | 000 | 1 | NIH | 2/21/2022 | $270,296 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | U01CA269147 | Low-Cost CRISPR-on-Paper for Cervical Cancer Screening at the Point of Care | 000 | 1 | NIH | 4/19/2022 | $547,265 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 farmington ave, asb #3 | farmington | CT | 06032-1956 | HARTFORD | USA | 90UCPH0020 | University of Connecticut Center for Excellence in Development Disabilities Education, Research, and Service: Expanding the Public Health Workforce within the Disability Network Program | 00 | 1 | ACL | 4/4/2022 | $113,670 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R21CA270973 | Interrupting tumor progression by restoration of VDR expression | 000 | 1 | NIH | 3/14/2022 | $191,675 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01DK129431 | Role of FGF23 in Bone, Kidney, Blood, Crosstalk in Sickle Cell Disease Mice | 000 | 1 | NIH | 3/25/2022 | $548,480 |
|
